Waive off ‘clinical trial mode’ for Bharat Biotech Covaxin, expert committee of regulator recommends to DCGI

If granted, the request would loosen the stringent conditions under which the vaccine is being administered, and possibly improve public acceptance of the vaccine.

from http://www.firstpost.com/health/waive-clinical-trial-mode-for-bharat-biotech-covaxin-expert-committee-of-regulator-recommends-to-dcgi-9403451.html